COMMUNIQUÉS West-GlobeNewswire
-
Alembic Therapeutics, LLC Announces Acquisition of NUVESSA® (metronidazole vaginal gel 1.3%) from Exeltis USA, Inc.
09/06/2026 -
Fertility Institute of Hawaii Joins Nucleus IVF+ Network as Demand for Genetic Optimization Continues to Expand
09/06/2026 -
Longeveron Granted Small or Medium-sized Enterprise (SME) Status by the European Medicines Agency (EMA)
09/06/2026 -
Legend Senior Living Earns Great Place to Work® Certification™ for Eighth Consecutive Year
09/06/2026 -
Ally Medical ER Is Coming to Magnolia
09/06/2026 -
Koi Peptides Survey Finds 75% of Lab Researchers Cite Sourcing Quality as Top Concern
09/06/2026 -
FDA Expands Sunscreen Options for the First Time in 20 Years
09/06/2026 -
AMN Healthcare Acquires Jaide Health to Expand Language Access Across the Patient Journey Through AI Technology
09/06/2026 -
AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market under NYSE American Rules
09/06/2026 -
Press Release Biocartis NV: Biocartis Announces Agreement with City of Hope to Explore Development of Rapid Gene Signature Test for Early Detection of Pancreatic Cancer
09/06/2026 -
Shattuck Labs Announces Exercise of Outstanding Common Stock Warrants and Provides Financial Update
09/06/2026 -
Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026
09/06/2026 -
Le gala Le Bal Rouge de la Fondation du CUSM recueille un montant record de 2 223 306 $ pour accélérer les découvertes en santé au site Glen du CUSM
09/06/2026 -
SCIENTURE Secures Formulary Coverage for REZENOPY™ with a Large National Health Plan and Expands Commercial Team
09/06/2026 -
Imviva Biotech Receives FDA Investigational New Drug Approval for CTA313, a Dual-Targeted CD19/BCMA Allogeneic CAR-T Cell Therapy for Autoimmune Diseases
09/06/2026 -
Windward Bio Doses First Patients in Phase 2 SIRIUS COPD Study of Ultra Long-Acting Anti-TSLP Antibody WIN378
09/06/2026 -
Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria
09/06/2026 -
Linnaeus Therapeutics Announces Selection of LNS8801 into the National Institute on Aging Interventions Testing Program
09/06/2026 -
Alps Group Inc Expands MyGenome Accreditation to Include Whole Genome Sequencing Under MS ISO 15189:2022
09/06/2026
Pages